Notícias Maia Biotechnology Inc - MAIA | Ações American Stock Exchange | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
Maia Biotechnology Inc (MAIA)
Maia Biotechnology Inc (MAIA) Notícias

Maia Biotechnology Inc (MAIA)

2,0801

-0,1599

( -7,14% )

Atualizado: 16:15:14

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

MAIA Biotechnology Announces Private Placement of Approximately $950,000

MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form D - Notice of Exempt Offering of Securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement

Form 8-K - Current report

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Maia Biotechnology

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições